Kojic acid in a body scrub sold in the United States is regulated by the FDA as a cosmetic ingredient under the Federal Food, Drug, and Cosmetic Act — not as a drug — provided the product's marketing claims stay within cosmetic territory. This means claims like 'brightening,' 'evens skin tone,' and 'smooths the appearance of uneven pigmentation' are generally acceptable, while claims like 'treats melasma,' 'reduces hyperpigmentation caused by sun damage,' or 'lightens skin' can push the product into drug classification territory, triggering far more stringent regulatory requirements including clinical substantiation and pre-market approval.
The FDA does not have a specific regulation setting a maximum concentration for kojic acid in cosmetics, but industry practice and safety assessments support concentrations of 1–2% in rinse-off applications like body scrubs. At these concentrations, safety data from the Cosmetic Ingredient Review (CIR) panel — the industry's self-regulatory body — generally supports use. The CIR has not flagged kojic acid as unsafe in rinse-off cosmetics at typical use levels.
Glycolic acid in the same product is similarly regulated as a cosmetic at concentrations up to roughly 10% in rinse-off applications. The FDA has not established a formal OTC monograph for glycolic acid, meaning there is no approved drug pathway for it in this context — all glycolic acid scrubs on the US market are cosmetics. However, the FDA has issued guidance noting that products making exfoliation claims should include appropriate consumer guidance, and very high concentrations (above 30%) raise safety questions.
California's Proposition 65 is a separate concern. If your kojic acid source contains trace levels of certain listed chemicals, or if the manufacturing process introduces them, a Prop 65 warning label may be required for products sold in California. Request a Prop 65 compliance statement from your ingredient supplier.
For export to the European Union, the regulatory picture is stricter. Kojic acid is listed in Annex III of EU Regulation 1223/2009 as a restricted substance: maximum 1% concentration in face products, with a specific warning statement required on the label. Body scrub applications are less explicitly regulated but should still adhere to the 1% ceiling as conservative practice. A qualified Person Responsible (PR) in the EU must file a Product Information File (PIF) and notify the product in the CPNP (Cosmetic Products Notification Portal) before the product can be sold in EU member states.
The UK post-Brexit has mirrored EU restrictions on kojic acid, requiring OPSS notification and a UK Responsible Person.
Your manufacturer should be able to advise on claim language and provide the safety documentation needed for each market. AJ Cosmo Labs connects you with manufacturers experienced in cross-market compliance — post your brief in the iOS app and specify your target markets so you receive bids from suppliers with the right regulatory expertise.
Ingredients in this answer: Kojic Acid · Glycolic Acid
Read the full guide on Private Label Kojic Acid Glycolic Acid Body Scrub Low MOQ →